(HealthDay)—Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, the U.S. Food and Drug ...

Cimzia (certolizumab) is a prescription drug used to treat plaque psoriasis, Crohn’s disease, and some types of arthritis, including rheumatoid arthritis. It’s given as an injection under the skin.

The Food and Drug Administration (FDA) has approved Cimzia to treat certain inflammatory conditions in adults, including rheumatoid arthritis. It’s also FDA approved for polyarticular juvenile ...

Each of these conditions causes your immune system (the body’s defense against disease) to mistakenly attack healthy cells. Cimzia and Humira help prevent the immune system from doing this. The drugs ...

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion from the EMA. UCB developed the AutoClicks ...

Rheumatoid arthritis (RA) is a type of arthritis that is considered an autoimmune disease. An autoimmune disease is when your immune system starts attacking your body. It causes pain and swelling in ...

Cimzia (certolizumab) is a prescription drug used to treat some types of arthritis and other conditions. Cimzia can cause side effects that range from mild to serious. Examples include infection and ...